Drug intelligence / Profile preview

betamethasone dipropionate spray 0.05%

Development stage
Approved
Lead developer
Promius Pharma, LLC
Modality
Small Molecules
Administration
Topical, Intramuscular, Intraarticular, Intralesional
01

Overview

DFD-01 is a novel topical formulation of betamethasone dipropionate, specifically as a 0.05% emollient spray or lotion, developed for the treatment of mild to moderate plaque psoriasis. It is classified as a mid-potency corticosteroid and was designed to optimize skin penetration while minimizing systemic absorption and side effects typical of higher potency steroids[1][2][4]. The mechanism of action involves agonism at the glucocorticoid receptor, leading to anti-inflammatory and immunosuppressive effects in psoriatic lesions[5][7]. Clinical studies have shown that DFD-01 provides efficacy comparable to superpotent corticosteroids (such as Diprolene) but with an improved safety profile suitable for longer-term use[1][2][8]. The vehicle formulation also enhances skin barrier function and flexibility[4].

Brand names
Sernivo
Other names
betamethasone dipropionate 0.05% sprayDFD01DFD-01DFD 01
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on betamethasone dipropionate spray 0.05%.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone dipropionate spray 0.05%.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call